Working to Eradicate Gynecologic Cancers

503
Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and HO-4318, in ovarian cancer

Sunday, March 29, 2015: 7:00 AM
Salon C-D (Hilton Chicago)
A. C. ElNaggar1, S. Naidu2, U. Saini2, R. Wanner2, M. Sudhakar2, D. E. Cohn1 and S. Karuppaiyah2
1The Ohio State University, James Cancer Hospital, Columbus, OH, 2The Ohio State University Medical Center, Columbus, OH
 
 
See more of: Poster Session B
See more of: Poster Session
<< Previous Presentation | Next Presentation >>